Synthesis and In Vitro Antitumor Activity of Naringenin Oxime and Oxime Ether Derivatives

Ahmed Dhahir Latif,Tímea Gonda,Máté Vágvölgyi,Norbert Kúsz,Ágnes Kulmány,Imre Ocsovszki,Zoltán Péter Zomborszki,István Zupkó,Attila Hunyadi
DOI: https://doi.org/10.3390/ijms20092184
IF: 5.6
2019-05-02
International Journal of Molecular Sciences
Abstract:Naringenin is one of the most abundant dietary flavonoids exerting several beneficial biological activities. Synthetic modification of naringenin is of continuous interest. During this study our aim was to synthesize a compound library of oxime and oxime ether derivatives of naringenin, and to investigate their biological activities. Two oximes and five oxime ether derivatives were prepared; their structure has been elucidated by NMR and high-resolution mass spectroscopy. The antiproliferative activity of the prepared compounds was evaluated by MTT assay against human leukemia (HL-60) and gynecological cancer cell lines isolated from cervical (HeLa, Siha) and breast (MCF-7, MDA-MB-231) cancers. Tert-butyl oxime ether derivative exerted the most potent cell growth inhibitory activity. Moreover, cell cycle analysis suggested that this derivative caused a significant increase in the hypodiploid (subG1) phase and induced apoptosis in Hela and Siha cells, and induced cell cycle arrest at G2/M phase in MCF-7 cells. The proapoptotic potential of the selected compound was confirmed by the activation of caspase-3. Antioxidant activities of the prepared molecules were also evaluated with xanthine oxidase, DPPH and ORAC assays, and the methyl substituted oxime ether exerted the most promising activity.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?